Ticker Symbol: TMBR
Timber Pharmaceuticals Inc
$0.51 - 20-12-2024 4 p.m. ET
Exchange: NYSE MKT LLC
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001504167
Company Profile
Timber Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases. The Company's investigational therapies have proven mechanisms-of-action backed by decades of clinical experience and well-established CMC (chemistry, manufacturing and control) and safety profiles. The Company is initially focused on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis (CI), facial angiofibromas (FAs) in tuberous sclerosis complex (TSC), and scleroderma.
Sector: Manufacturing
Industry: Medicinal and Botanical Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 1098 Hamilton Ct
Website: www.timberpharma.com
CEO: N/A
Tags:
- Producer Manufacturing
- Miscellaneous Manufacturing
- Health Technology
- Pharmaceuticals: Major
- Manufacturing
- Medicinal and Botanical Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $2.91
Change:
$0.06
(
2.10%)
Days Range: $2.81 - $2.91
Beta: -
52wk. High: $3.39
52wk. Low: $0.05
Ytd. Change 64.96%
50 Day Moving Average: $2.95
200 Day Moving Average: $2.09
Shares Outstanding: 3432735
Valuation
Market Cap: 998.9M
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A